Table 1.
THA | IV TXA (n = 108) | Topical TXA (n = 48) | P |
---|---|---|---|
Sex, M/Fa | 42/66 | 27/21 | .044 |
| |||
Mean (SD) | |||
Age, y | 59 (12.9) | 63 (14.4) | .086 |
Height, m | 1.67 (0.092) | 1.70 (0.107) | .068 |
Weight, kg | 87.4 (23.1) | 88.3 (24.8) | .823 |
BMI, kg/m2 | 31.2 (7.2) | 30.4 (7.5) | .534 |
| |||
TKA | IV TXA (n = 83) | Topical TXA (n = 52) | P |
| |||
Sex, M/F | 32/51 | 23/29 | .577 |
| |||
Mean (SD) | |||
Age, y | 62 (10.6) | 63 (9. 35) | .418 |
Height, m | 1.67 (0.114) | 1.69 (0.121) | .370 |
Weight, kg | 98 (20.9) | 100 (27.1) | .621 |
BMI, kg/m2 | 35.3 (7.46) | 34.8 (7.78) | .736 |
Abbreviations: BMI, body mass index; IV, intravenous; THA, total hip arthroplasty; TKA, total knee arthroplasty; TXA, tranexamic acid.
Significant difference.